窝转脊椎动物
发表于 2025-3-27 00:08:59
http://reply.papertrans.cn/67/6604/660380/660380_31.png
Feature
发表于 2025-3-27 03:48:58
http://reply.papertrans.cn/67/6604/660380/660380_32.png
饥荒
发表于 2025-3-27 08:00:56
http://reply.papertrans.cn/67/6604/660380/660380_33.png
Arbitrary
发表于 2025-3-27 12:21:05
http://reply.papertrans.cn/67/6604/660380/660380_34.png
流逝
发表于 2025-3-27 17:07:20
http://reply.papertrans.cn/67/6604/660380/660380_35.png
Vulnerary
发表于 2025-3-27 20:56:02
Sabrina Krausss can be even greater. For example, Pfizer generated about 90% of its worldwide revenues in 2002 with just 8 products. Any shortfall of a promising late-stage drug candidate would have left Pfizer with a gaping hole in its product portfolio. In order to deal with these risks, many pharmaceutical com
巩固
发表于 2025-3-27 23:07:36
Julia Plugmann,Philipp Plugmanns can be even greater. For example, Pfizer generated about 90% of its worldwide revenues in 2002 with just 8 products. Any shortfall of a promising late-stage drug candidate would have left Pfizer with a gaping hole in its product portfolio. In order to deal with these risks, many pharmaceutical com
nonplus
发表于 2025-3-28 04:26:46
Arno Lammertss can be even greater. For example, Pfizer generated about 90% of its worldwide revenues in 2002 with just 8 products. Any shortfall of a promising late-stage drug candidate would have left Pfizer with a gaping hole in its product portfolio. In order to deal with these risks, many pharmaceutical com
FOLD
发表于 2025-3-28 06:33:28
http://reply.papertrans.cn/67/6604/660380/660380_39.png
Diastole
发表于 2025-3-28 12:20:05
Andreas Kirstas well as how one defines a dose response relationship using intravenous critical care medicines were discussed as important clinical trial issues. The benefit versus risk data on currently available thrombolytic agents was reviewed and the potential roles for adjunctive agents addressed. Overall s